Yu Fangfei, Li Shuang, Li Zunjiang, Mo Zhaofan, Liu Rong, Zhao Jiaying, Ding Banghan, Yi Wei, Xu Nenggui
Clinical Medical College of Acupuncture, Moxibustion and Rehabilitation, Guangzhou University of Traditional Chinese Medicine, Guangzhou, China.
The First Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Front Neurol. 2025 May 19;16:1546194. doi: 10.3389/fneur.2025.1546194. eCollection 2025.
The adjunctive effect of acupuncture for cerebral infarction (CI) remains inconsistent. We aimed to determine its anti-inflammatory effect, assess safety, and summarize the adjunctive use of acupuncture for CI.
We identified qualified randomized controlled trials (RCTs) from eight literature databases. Frequency analysis and Apriori association analysis were conducted using SPSS Modeler 18.0 and SPSS 26.0 software. A meta-analysis was performed using Stata 17.0 software. The credibility of the meta-results and the certainty of the evidence was assessed using trial sequential analysis (TSA) and GRADE methods, respectively.
A total of 43 RCTs were included, comprising 3,861 participants. Acupuncture with intermittent treatment (5-7 times per week), a combination of multiple points and multiple meridians (an average of 9.35 points in each prescription), typically lasting for 2-4 weeks, was commonly used for CI treatment. Meta-analysis indicated that the adjunctive use of acupuncture reduced levels of TNF-α (SMD = -1.36; 95% CI -1.51 to -1.20, < 0.01), hs-CRP (SMD = -0.86; 95% CI -0.99 to -0.74, < 0.01), and IL-6 (SMD = -0.85; 95% CI -1.08 to -0.62, < 0.01), and decreased the rate of adverse events (RR = 0.71; 95% CI 0.49 to 1.01; < 0.05). The certainty of the evidence was rated as moderate to high.
Intermittent acupuncture treatment lasting at least 2 w was commonly used for CI patients, typically involving multiple acupuncture points and meridians. Acupuncture demonstrated an anti-inflammatory effect in the treatment of CI. However, due to the low quality of the existing literature, high-quality randomized controlled trials (RCTs) are required to confirm these results in the future.
https://www.crd.york.ac.uk/prospero/, identifier CRD42017078583.
针刺治疗脑梗死(CI)的辅助作用仍不一致。我们旨在确定其抗炎作用,评估安全性,并总结针刺在CI治疗中的辅助应用。
我们从八个文献数据库中筛选出合格的随机对照试验(RCT)。使用SPSS Modeler 18.0和SPSS 26.0软件进行频率分析和Apriori关联分析。使用Stata 17.0软件进行荟萃分析。分别使用试验序贯分析(TSA)和GRADE方法评估荟萃分析结果的可信度和证据的确定性。
共纳入43项RCT,包括3861名参与者。CI治疗常用的针刺方法为间歇治疗(每周5 - 7次),多穴位、多经络联合使用(每个处方平均9.35个穴位),通常持续2 - 4周。荟萃分析表明,针刺辅助治疗可降低TNF-α水平(标准化均数差[SMD]= -1.36;95%可信区间[CI] -1.51至-1.20,P<0.01)、超敏C反应蛋白(hs-CRP)水平(SMD = -0.86;95%CI -0.99至-0.74,P<0.01)和白细胞介素-6(IL-6)水平(SMD = -0.85;95%CI -1.08至-0.62,P<0.01),并降低不良事件发生率(风险比[RR]= 0.71;95%CI 0.49至1.01;P<0.05)。证据的确定性被评为中等至高。
CI患者常用持续至少2周的间歇针刺治疗,通常涉及多个穴位和经络。针刺在CI治疗中显示出抗炎作用。然而,由于现有文献质量较低,未来需要高质量的随机对照试验来证实这些结果。